Platelet-leukocyte interactions in hemodialysis patients: Culprit or bystander?

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 3, 2006, Pages 461-470

  Sirolli, V ^a   Amoroso, L ^a   Pietropaolo, M ^a   Grandaliano, G ^a   Pertosa, G ^b   Bonomini, Mario ^a,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Ospedale SS Annunziata   (Italy)

Author keywords

Adhesion molecules; Biocompatibility; Dialyzer membrane; Hemodialysis; Platelet monocyte interaction; Platelet neutrophil interaction; Reactive oxygen species

Indexed keywords

CELL ADHESION MOLECULE; CUPROPHANE;

ATHEROGENESIS; CELL INTERACTION; HEMODIALYSIS PATIENT; HEMOSTASIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; LEUKOCYTE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; UREMIA;

EID: 33750088705     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900302     Document Type: Review

References (82)

1. Hakim R.M. 1993. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44:484.
2. Opatrny K. Jr. 2003. Clinical importance of biocompatibility and its effects on hemodialysis treatment. Nephrol. Dial. Transplant. 18(S):41.
3. Craddock P.R., J. Ferh, K.L. Brigham, R.S. Kronenberg and H.S. Jacobs. 1977. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med. 296:769.
4. Mahiout A., A. Jorres, H. Meinhold and M. Kessel. 1986. Prostaglandin production and extracorporeal complement activation by dialyzer membranes. Tran. Am. Soc. Artif. Intern. Organs 32:88.
5. Mahiout A., A. Jorres, G. Schultze, H. Meinhold and M. Kessel. 1989. Eicosanoid release as laboratory indicator of biocompatibility. Artif. Organs 13:251.
6. Pereira B.J.G. and C.A. Dinarello. 1994. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol. Dial. Transplant. 9(S):60.
7. Schmidt B. and S.K. Mujais. 1995. Evaluation of dialysis membrane-blood compatibility: Experimental methods. Contrib. Nephrol. 113:32.
8. Bonomini M., S. Stuard and A. Albertazzi. 1997. Cell-associated adhesion molecules in hemodialysis. Int. J. Immunopathol. Pharmacol. 10:37.
9. Dhodt A., R. Vanholder and N. Lameire. 1998. Hemodialysis-related bioincompatibility and adhesion molecules. Int. J. Artif. Organs 21:501.
10. Blumenstein M., H.W.L. Ziegler-Heitbrock, B. Schiller, B. Schmidt, R.A. Ward and H.J. Gurland. 1990. Differential activation of monocytes in haemodialysis patients exposed to different types of membranes. Scand. J. Immunol. 31:183.
11. Himmelfarb J., K.A. Ault, D. Holbrook, D.A. Leeber and R.M. Hakim. 1993. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J. Am. Soc. Nephrol. 4:178.
12. Rinder H.M., J.L. Bonan, C.S. Rinder, K.A. Ault and B.R. Smith. 1991. Dynamics of leukocyte platelet adhesion in whole blood. Blood 78:1730.
13. deGaetano G., C. Cerletti and V. Evangelista. 1999. Recent advances in platelet-polymorphonuclear leukocyte interactions. Haemostasis 29:41.
14. Faint R.W. 1992. Platelet-neutrophil interactions: their significance. Blood Rev. 6:83.
15. Bazzoni G., E. Decana and A. Del Maschio. 1991. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 76:491.
16. McEver R.P. 2000. Adhesive interactions of leukocytes, platelets and the vessel wall during hemostasis and inflammation. Thromb. Haemost. 86:746.
17. Freedman J.E. and J. Loscalzo. 2002. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 105:2130.
18. Bonomini M., V. Sirolli, S. Stuard and N. Settefrati. 1999. Interactions between platelets and leukocytes during hemodialysis. Artif. Organs 23:23.
19. Larsen E., A. Celi, G.E. Gilbert, B.C. Furie, J.K. Erban, R. Bonfanti, D.D. Wagner and B. Furie. 1989. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305.
20. Rinder H.M., J.L. Bonan, C.S. Rinder, K.A. Ault and B.R. Smith. 1991. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78:1760.
21. Ott I., F.J. Neumann, M. Gawaz, M. Schmitt and A. Schomig. 1996. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94:1239.
22. Faraday N., J.B. Braunstein, A.W. Heldman, E.D. Bolton, K.A. Chiles, G. Gerstenblith and S.P. Schulman. 2004. Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets 15:9.
23. Mickelson J.K., N.M. Lakkis, G. Villarreal-Levy, B.J. Hughes and S.W. Smith. 1996. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J. Am. Coll. Cardiol. 28:345.
24. Neumann F.J., I. Ott, M. Gawaz, G. Puchner and A. Schomig. 1996. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J. Am. Coll. Cardiol. 27:819.
25. Russwurm S., J. Vickers, A. Meier-Hellmann, P. Spangenberg, D. Bredle, K. Reinhart and W. Losche. 2002. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 17:263.
26. Kirschenbaum L.A., D. Adler, M.E. Astiz, R.S. Barua, D. Saha and E.C. Rackow. 2002. Mechanisms of platelet-neutrophil interactions and effects on cell filtration in septic shock. Shock 17:508.
27. Rinder C.S., J.L. Bonan, H.M. Rinder, J. Mathew, R. Hines and B.R. Smith. 1992. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 79:1201.
28. Peters M.J., R.S. Heyderman, S. Faust, G.L. Dixon, D.P. Inwald and N.J. Klein. 2003. Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J. Leukoc. Biol. 73:722.
29. Tuttle H.A., G. Davis-Gorman, S. Goldman, J.G. Copeland and P.E. McDonagh. 2003. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc. Diabetol. 4:2.
30. Brady H.R., A. Papayianni and C.N. Serhan. 1994. Leukocyte adhesion promotes biosynthesis of lipoxygenase products by transcellular routes. Kidney Int. 45(S):90.
31. Evangelista V., S. Manarini, R. Sideri, S. Rotondo, N. Martelli, A. Piccoli, L. Totani, P. Piccardoni, D. Vestweber and G. de Gaetano. 1999. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93:876.
32. Peters M.J., G. Dixon, K.T. Kotowicz, D.J. Hatch, R.S. Heyderman and N.J. Klein. 1999. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br. J. of Haemat. 106:391.
33. Nash G.B. 1994. Adhesion between neutrophils and platelets: a modulator of thrombotic and inflammatory events? Thromb. Res. 74(S):3.
34. Evangelista V., P. Piccardoni, J.G. White, G. de Gaetano and C. Cerletti. 1993. Cathepsin-G dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: Role of P-selectin-mediated cell-cell adhesion. Blood 81:2947.
35. Ware J.A. and D.D. Heistad. 1993. Platelet endothelium interactions. N. Engl. J. Med. 328:628.
36. Gawaz M.P., S.K. Mujais, B. Schmidt and H.J. Gurland. 1994. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 46:489.
37. Kawabata K., S. Nakai, M. Miwa, T. Sugiura, Y. Otsuka, T. Shinzato, Y. Hiki, I. Tomimatsu, Y. Ushida, F. Hasono and K. Maeda. 2002. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis. Nephron 90:391.
38. Stuard S., M.P. Carreno, J.L. Poignet, A. Albertazzi and N. Haeffner-Cavaillon. 1995. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int. 48:93.
39. Stuard S., M. Bonomini, N. Settefrati and A. Albertazzi. 1998. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach. Int. J. Artif. Organs. 21:75.
40. Bonomini M., V. Sirolli, N. Settefrati, S. Stuard, F. Tropea, L. Di Liberato, C. Tetta and A. Albertazzi. 1999. Surface antigen expression and platelet neutrophil interactions in haemodialysis. Blood Purif. 17:107.
41. Sirolli V., S. Di Stante, S. Stuard, L. Di Liberato, L. Amoroso, P. Cappelli and M. Bonomini. 2000. Biocompatibility and functional performance of a polyethylene glicol acid-grafted cellulosic membrane for hemodialysis. Int. J. Artif. Organs 23:356.
42. Sirolli V., E. Ballone, L. Amoroso, L. Di Liberato, R. Di Mascio, P. Cappelli, A. Albertazzi and M. Bonomini. 1999. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes. Int. J. Artif. Organs 22:536.
43. Sirolli V., E. Ballone, S. Di Stante, L. Amoroso and M. Bonomini. 2002. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Int. J. Artif. Organs 25:529.
44. Bonomini M., S. Di Stante and V. Sirolli. 2003. Biocompatibility of DIAPES. Contrib. Nephrol. 138:117.
45. Carreno M.P., S. Stuard, M. Bonomini, N. Settefrati, C. Tetta, A. Albertazzi and N. Haeffner-Cavaillon. 1996. Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol. Dial. Transplant. 11:2248.
46. Himmelfarb J., P. Zaoui and R. Hakim. 1992. Modulation of granulocyte LAM 1 and MAC1 during dialysis a prospective, randomized controlled trial. Kidney Int. 41:388.
47. Nagata K., T. Tsuji, N. Todoroki, Y. Katagiri, K. Tanoue, H. Yamazaki, N. Hanai and T. Irimura. 1993. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin. J. Immunol. 151:3267.
48. Schomig M., A. Eisenhardt and E. Ritz. 2000. The microinflammatory state of uremia. Blood Purif. 8:327.
49. Bonomini M., S. Stuard, M.P. Carreno, N. Settefrati, P. Santarelli, N. Haeffner-Cavaillon and A. Albertazzi. 1997. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron 75:402.
50. Rosenkranz A.R., E. Tempi, O. Traindl, H. Heinzl and G.J. Zlabinger. 1994. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membrane. Clin. Exp. Immunol. 98:300.
51. Cappelliere-Blandin C., T. Delaveau and B. Descamps-Latscha. 1991. Structural modifications of human beta 2-microglobulin treated with oxygen-derived radicals. Biochem. J. 277:175.
52. Weiss S.J., J. Young, A.F. LoBuglio, A. Slivka and N.F. Nimer. 1981. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J. Clin. Invest. 68:714.
53. Ager A. and J.L. Gordon. 1984. Differential effects of hydrogen peroxide on indices of endothelial cell function. J. Exp. Med 159:592.
54. Schulman G., A. Fago, A. Gung, K. Badr and R. Hakim. 1991. Complement activation retards resolution of ischemic renal failure in the rat. Kidney Int. 40:1069.
55. Holliwell B. 1993. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23(S):118.
56. Yagi K. 1986. A biochemical approach to atherogenesis. Trends Biochem. Sci. 11:18.
57. Linder A., B. Charna, D.J. Sherrand and B.H. Scribner. 1974. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med. 290:697.
58. Amann K., M.L. Gross and E. Ritz. 2004. Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target. J. Am. Soc. Nephrol. 15:1664.
59. Foley R.N., P.S. Parfrey and M.J. Sarnak. 1998. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol. 9(S):S16.
60. Herzog C.A., J.Z. Ma and A.J. Collins. 1998. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med. 339:799.
61. Galle J. and C. Wanner. 1997. Oxidative stress and vascular injury - relevant for atherogenesis in uraemic patients? Nephrol. Dial. Transplant. 12:2480.
62. Neumann F.J., D. Zohlnhofer, L. Fakhoury, I. Ott, M. Gawaz and A. Schomig. 1999. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll. Cardiol. 34:1420.
63. Celi A., G. Pellegrini, R. Lorenzet, A. De Blasi, N. Ready, B.C. Furie and B. Furie. 1994. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U.S.A. 91:8767.
64. Neumann F.J., N. Marx, M. Gawaz, K. Brand, I. Ott, C. Rokitta, C. Sticherling, C. Meinl, A. May and A. Schomig. 1997. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95:2387.
65. Weyrich A.S., T.M. McIntyre, R.P. McEver, S.M. Prescott and G.A. Zimmerman. 1995. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-kappaB translocation. J. Clin. Invest. 95:2297.
66. Weyrich A.S., M.R. Elstad, R.P. McEver, T.M. McIntyre, K.L. Moore, J.H. Morrissey, S.M. Prescott and G.A. Zimmerman. 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97:1525.
67. Huo Y. and F.K. Ley. 2004. Role of platelets in the development of atherosclerosis. Trends Cardiovasc. Med. 14:18.
68. Huo Y., A. Schober, S.B. Forlow, D.F. Smith, M.C. Hyman, S. Jung, D.R. Littman, C. Weber and K. Ley. 2003. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9:61.
69. Van der Wal A.C. and A.E. Becker. 1999. Atherosclerotic plaque rupture - basis of plaque stability and instability. Cardiovasc. Res. 41:344.
70. rd and R.J. Goldberg. 2001. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J. Am. Coll. Cardiology 38:1002.
71. Furman M.I., S.E. Benoit, M.R. Barnard, C.R. Valeri, M.I. Borbone, R.C. Becker, H.B. Hechtman and A.D. Michelson. 1998. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J. Am. Coll. Cardiology 31:352.
72. Sarma J., C.A. Laan, S. Alam, A. Jha, K.A. Fox and I. Dransfield. 2002. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105:2166.
73. Harding S.A., A.J. Sommerfield, J. Sarma, P.J. Twomey, D.E. Newby, B.M. Frier and K.A. Fox. 2004. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176(2):321.
74. Villmow T., B. Kemkes-Matthes and A.C. Matzdorff. 2002. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb. Res. 108(2):139.
75. Wun T., M. Cordoba, A. Rangaswami, A.W. Cheung and T. Paglieroni. 2002. Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin. Lab. Haematol. 24(2):81.
76. Harding S.A., J. Sarma, D.H. Josephs, N.L. Cruden, J.N. Din, P.J. Twomey, K.A.A. Fox and D.E. Newby. 2004. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation 109:1926.
77. Michelson A.D., M.R. Barnard, L.A. Krueger, C.R. Valeri and M.I. Furman. 2001. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533.
78. Ray M.J., D.L. Walters, J.N. Bett, J. Cameron, P. Wood and C.N. Aroney. 2005. Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by abciximab. Int. J. Cardiol. 101(2):249.
79. Ashman N., M.G. Macey, S.L. Fan, U. Azam and M.M. Yaqoob. 2003. Increased platelet-monocyte aggregates and cardiovascular disease in end stage renal failure patients. Nephrol. Dial. Transplant. 18:2088.
80. Henn V., J.R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus and R.A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591.
81. Lindmark E., T. Tenno and A. Siegbahn. 2000. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler. Thromb. Vasc. Biol. 20:2322.
82. Schonbeck U. and P. Libby. 2001. CD40 signaling and plaque instability. Circ. Res. 89:1092.